Skip to content

LA JOLLA PHARMACEUTICAL CO

CIK 0000920465

← back to feed
Revenue (TTM)
$50.34M
+126.6% YoY Q2 Aug 2022
Net Income (TTM)
$3.93M
+149.9% YoY Q2 Aug 2022
EPS Diluted (TTM)
$0.11
+140.3% YoY Q2 Aug 2022
Gross Margin
90.9%
Q2 Aug 2022
Operating Margin
2.4%
Q2 Aug 2022
Net Margin
7.8%
Q2 Aug 2022
Free Cash Flow (TTM)
−$27.16M
Q2 Aug 2022
Cash
$48.34M
Q2 Aug 2022
Total Debt
$124.32M
Q2 Aug 2022
Shares Outstanding
24.94M sh
Q2 Aug 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings